Evidence-based treatment for gynoid lipodystrophy: A review of the recent literature

J Cosmet Dermatol. 2018 Dec;17(6):977-983. doi: 10.1111/jocd.12555. Epub 2018 Apr 30.

Abstract

Gynoid lipodystrophy (GLD) is a structural, inflammatory, and biochemical disorder of the subcutaneous tissue causing alterations in the topography of the skin. Commonly known as "cellulite," GLD affects up to 90% of women, practically in all stages of the life cycle, beginning in puberty. It is a clinical condition that considerably affects the patients' quality of life. It is a frequent reason for consultation, although the patients resort to empirical, improvised, nonevidence-based treatments which discourage and can be a source of frustration not only because of the lack of results but also due to the complications derived from those treatments. In this article, a panel of experts from different specialties involved in the management of this clinical skin disorder presents the results of a systematic literature search and of the consensus discussion of the evidence obtained from different treatments currently available. The analysis was divided into topical, systemic, noninvasive, and minimally invasive treatments.

Keywords: cellulite; celulitis; diagnosis; diagnóstico; etiopathogenesis; etiopatogenia; ginoide; gynoid; lipodistrofia; lipodystrophy; piel; skin; tratamiento; treatment.

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Administration, Oral
  • Carbon Dioxide / therapeutic use
  • Cellulite / classification
  • Cellulite / etiology*
  • Cellulite / therapy*
  • Evidence-Based Medicine
  • Humans
  • Massage
  • Mesotherapy
  • Pharmaceutical Preparations*
  • Phototherapy
  • Plant Extracts / therapeutic use
  • Radiofrequency Therapy
  • Sound

Substances

  • Pharmaceutical Preparations
  • Plant Extracts
  • Carbon Dioxide